In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Cardiovascular Disease in the Elderly

CRT Online Plenary Meeting , 2 afternoon sessions from 14:00 - 16:45 CET

12/05/2021 14:00 13/05/2021 16:45 Europe/Paris Cardiovascular Disease in the Elderly

Access event page

contact@escardio.org DD/MM/YYYY
Online
event

Summary

Chairpersons:  Dr Maddalena LETTINO (ESC), Prof. Julia MASCHERBAUER (ESC), Dr Matias NORDABY (Boehringer-Ingelheim), Dr André ZIEGLER (Roche Diagnostics), Dr Isabelle RICHARD-LORDEREAU (Amgen), Industry chair of the CRT

 



12 May Replay - Session 1

12 May Replay - Session 2

13 May Replay - Session 1

13 May Replay - Session 2

 

Background and objectives of the meeting

The growing elderly population worldwide represents a major challenge for care-givers, healthcare providers and politicians.

Due to the life-long exposure to cardiovascular risk factors and the age-related comorbidities, cardiovascular diseases in elderly patients have a high prevalence and are frequently complicated, thus deserving a multifactorial approach.

Major problems to deal with are: paucity of scientific evidence from dedicated clinical trials, a narrow therapeutic window for most of the recommended therapies, frailty and cognitive deterioration, all affecting quality of care and outcome.

This meeting will appraise the burden of ageing in real life and the opportunity to revisit cardiovascular research, as well as pharmacological and interventional treatments in the elderly, with a final focus on quality of life and patient’s priorities.

Programme

View the biographies

DAY 1

12 MAY 2021 – 14:00 – 16:45 CET

14:00 - 14:05

Welcome and introduction

Chairpersons

14:05 - 14:15

Introductory talk: How to define and measure ageing?

Dr Maddalena Lettino, IT

Dr Isabelle Richard-Lordereau, Amgen

SESSION 1 - THE BURDEN OF AGEING IN REAL LIFE

14:15 - 14:25

Co-Morbidities and Risk Factors in the Ageing Population

Prof. Frank Visseren, NL

14:25 - 14:35

Benefits of Primary Prevention/ Lifestyle in the Elderly

Dr Deirdre E. O’Neill, CA

14:35 - 15:15

Discussion

15:15 - 15:45

Break

SESSION 2 – TAILORED CVD MANAGEMENT IN THE ELDERLY

15:45 - 15:55

EMA recommendations
- for CVD research in the Elderly
- for trials for the elderly / looking for an indication
- lack of evidence

Dr Kristina Dunder, NO

15:55 - 16:05

Similarities and differences in CV ageing in men and women

Prof. Geneviève Derumeaux, FR

16:05 - 16:45

Discussion

16:45

Wrap-up - End of DAY 1 – Let’s meet tomorrow for the 2 final sessions

 

 

DAY 2

13 MAY 2021 - 14:00 – 16:45 CET

 14:00 - 14:05

Summary of Day 1

Chairpersons

SESSION 3 - LEARNINGS FROM TREATMENTS SPECIFICITIES IN THE ELDERLY

14:05 - 14:15

Challenges in Antithrombotics Treatments
Antiplatelets – Anticoagulants
(discussion on combination)

Prof. Stefan Hohnloser, DE

14:15 - 14:25

Challenges in Intervention
Decision-Making for Invasive Procedures in the Elderly (PCI, TAVI, Mitraclip…)

Prof. Jean-Philippe Collet, FR

14:25 - 15:00

Discussion

15:00 - 15:30

Break

SESSION 4 - HOW TO ARTICULATE SOCIAL CARE AND HEALTH CARE PRIORITIES?

15:30 - 15:40

The Patient Perspective – Interview of a Patient

Video

15:40 - 15:50

Adding Years to Life or Life to Years: The Ethical dimension (choices tree for Palliative Care/ focus on CV / Quality of Life)

Dr Herbert Watzke, AT

15:50 - 16:35

Discussion

16:35 - 16:45

Wrap-up – Key messages – Next steps - Publication
END OF DAY 2